Heideman DA - Search Results

1

EGFR and KRAS quality assurance schemes in pathology: generating normative data for molecular predictive marker analysis in targeted therapy.

Thunnissen E, Bovée JV, Bruinsma H, van den Brule AJ, Dinjens W, Heideman DA, Meulemans E, Nederlof P, van Noesel C, Prinsen CF, Scheidel K, van de Ven PM, de Weger R, Schuuring E, Ligtenberg M. Thunnissen E, et al. Among authors: heideman da. J Clin Pathol. 2011 Oct;64(10):884-92. doi: 10.1136/jclinpath-2011-200163. J Clin Pathol. 2011. PMID: 21947301

2

Dramatic response to low-dose erlotinib of epidermal growth factor receptor mutation-positive recurrent non-small cell lung cancer after severe cutaneous toxicity.

Lind JS, Postmus PE, Heideman DA, Thunnissen EB, Bekers O, Smit EF. Lind JS, et al. Among authors: heideman da. J Thorac Oncol. 2009 Dec;4(12):1585-6. doi: 10.1097/JTO.0b013e3181bbb2b9. J Thorac Oncol. 2009. PMID: 20009914 Free article.

3

p16(INK4a) immunostaining as an alternative to histology review for reliable grading of cervical intraepithelial lesions.

Dijkstra MG, Heideman DA, de Roy SC, Rozendaal L, Berkhof J, van Krimpen K, van Groningen K, Snijders PJ, Meijer CJ, van Kemenade FJ. Dijkstra MG, et al. Among authors: heideman da. J Clin Pathol. 2010 Nov;63(11):972-7. doi: 10.1136/jcp.2010.078634. Epub 2010 Oct 5. J Clin Pathol. 2010. PMID: 20924035

4

Bronchioloalveolar adenocarcinoma and pulmonary langerhans cell histiocytosis in a patient with MUTYH-associated polyposis.

von der Thüsen JH, van de Wetering MD, Westermann AM, Heideman DA, Thunnissen E. von der Thüsen JH, et al. Among authors: heideman da. J Clin Oncol. 2011 Mar 10;29(8):e188-90. doi: 10.1200/JCO.2010.32.1026. Epub 2010 Dec 28. J Clin Oncol. 2011. PMID: 21189386 No abstract available.

5

KRAS and BRAF mutation analysis in routine molecular diagnostics: comparison of three testing methods on formalin-fixed, paraffin-embedded tumor-derived DNA.

Heideman DA, Lurkin I, Doeleman M, Smit EF, Verheul HM, Meijer GA, Snijders PJ, Thunnissen E, Zwarthoff EC. Heideman DA, et al. J Mol Diagn. 2012 May-Jun;14(3):247-55. doi: 10.1016/j.jmoldx.2012.01.011. Epub 2012 Mar 14. J Mol Diagn. 2012. PMID: 22425762 Free article.

6

Prolonged sampling of spontaneous sputum improves sensitivity of hypermethylation analysis for lung cancer.

Hubers AJ, Heideman DA, Herder GJ, Burgers SA, Sterk PJ, Kunst PW, Smit HJ, Postmus PE, Witte BI, Duin S, Snijders PJ, Smit EF, Thunnissen E. Hubers AJ, et al. Among authors: heideman da. J Clin Pathol. 2012 Jun;65(6):541-5. doi: 10.1136/jclinpath-2012-200712. Epub 2012 Mar 29. J Clin Pathol. 2012. PMID: 22461647

7

EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma.

Smits AJ, Kummer JA, Hinrichs JW, Herder GJ, Scheidel-Jacobse KC, Jiwa NM, Ruijter TE, Nooijen PT, Looijen-Salamon MG, Ligtenberg MJ, Thunnissen FB, Heideman DA, de Weger RA, Vink A. Smits AJ, et al. Among authors: heideman da. Cell Oncol (Dordr). 2012 Jun;35(3):189-96. doi: 10.1007/s13402-012-0078-4. Epub 2012 Apr 12. Cell Oncol (Dordr). 2012. PMID: 22528563 Free PMC article.

8

Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancer.

Vincenten J, Smit EF, Vos W, Grünberg K, Postmus PE, Heideman DA, Snijders PJ, Meijer G, Kuik J, Witte BI, Thunnissen E. Vincenten J, et al. Among authors: heideman da. J Thorac Oncol. 2012 Oct;7(10):1522-7. doi: 10.1097/JTO.0b013e3182635a91. J Thorac Oncol. 2012. PMID: 22982653 Free article.

9

Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.

Thunnissen E, Boers E, Heideman DA, Grünberg K, Kuik DJ, Noorduin A, van Oosterhout M, Pronk D, Seldenrijk C, Sietsma H, Smit EF, van Suylen R, von der Thusen J, Vrugt B, Wiersma A, Witte BI, den Bakker M. Thunnissen E, et al. Among authors: heideman da. Virchows Arch. 2012 Dec;461(6):629-38. doi: 10.1007/s00428-012-1324-x. Epub 2012 Oct 12. Virchows Arch. 2012. PMID: 23064619

10

A patient with simultaneously appearing adenocarcinoma and small-cell lung carcinoma harbouring an identical EGFR exon 19 mutation.

van Riel S, Thunnissen E, Heideman D, Smit EF, Biesma B. van Riel S, et al. Ann Oncol. 2012 Dec;23(12):3188-3189. doi: 10.1093/annonc/mds525. Epub 2012 Oct 18. Ann Oncol. 2012. PMID: 23079729 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

225 results

Search Page